I am still targeting a zip-up price occurance before Christmas --by or before 12/23 when the European Union gives approval to Optimer's DIFICID as recommended 9/23/2011 by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).
"The European Commission generally follows the recommendations of the CHMP and delivers its final decision within three months of the CHMP opinion."
This information from optimerpharma.com news release 9/23/2010.
<<Health Canada awarded Optimer priority review of the DIFICID NDS, reducing the time to a potential regulatory approval in Canada. To address the country-specific needs and relationships, Optimer also announced the establishment of Optimer Pharmaceuticals Canada, Inc., a subsidiary from which the Company plans to make DIFICID available in Canada.>> 11/3/11 on Optimerpharma.com PR
I don't have a timeline for Canada. Anybody have it?
This expansion of Optimer validates the need for the 200M shares -- I believe common and preferred will be issued at the appropriate times, some to raise capital and some as incentives to new administrative candidates in Canada and Europe. Maybe even some to prevent an unwelcomed takeover.